Feedback / Questions
hydrogen sulphide-releasing derivative of naproxen (ATB-346) - Antibe
https://www.businesswire.com/news/home/20190827005253/en/Antibe-Therapeutics-Update-Phase-2B-Dose-Ranging-Efficacy
Aug 27, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next